Depression and Inflammation in Women with Breast Cancer: Risk and Resilience Factors

By sjmartinez • May 14, 2025

Korecki JRT, Slavich GM, Ganz PA, Irwin MR, Cole S, Crespi CM, Bower JE. Depression and Inflammation in Women with Breast Cancer: Risk and Resilience Factors. Biopsychosoc Sci Med. 2025 May 9. doi: 10.1097/PSY.0000000000001398. Epub ahead of print. PMID: 40359350.

Tags: and Energy study, BMI, body mass index, breast cancer survivors, C-reactive protein, CBT-I, Center for Epidemiological Studies Depression Scale, CES-D, CI, cognitive behavioral therapy for insomnia, confidence interval, CRP, depression, Hematology/Oncology, IL-6, Inflammation, interleukin, Life Orientation Test-Revised, lifetime stressor exposure, LOT-R, PA, physical activity, Pittsburgh Sleep Quality Index, PSQI, Publications, Research on Inflammation, resilience, RISE, SD, standard deviation, Strain, Stress, Stress and Adversity Inventory, TNF-α, Tumor necrosis factor-α

Somatic Tumor Next-Generation Sequencing in US Veterans With Metastatic Prostate Cancer

Valle LF, Li J, Desai H, Hausler R, Haroldsen C, Chatwal M, Ojo M, Kelley MJ, Rebbeck TR, Rose BS, Rettig MB, Nickols NG, Garraway[...]

Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

Rugo HS, Bardia A, Gradishar WJ, Hamilton EP, Hurvitz SA, Jhaveri K, Mahtani R, Tolaney SM. Expert consensus on treating HR+/HER2- metastatic breast cancer based[...]

Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients

Oh MS, Garon EB, Lisberg AE, Cummings AL, Barrett A, Ashok A, Mauer E, Yilma B, Goldman JW. Brief Report: The Genomic Landscape of Small[...]